AGTC insider filings
APPLIED GENETIC TECHNOLOGIES CORP — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-12-01. Screen AGTC transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for AGTC between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — APPLIED GENETIC TECHNOLOGIES CORP
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2022-12-01 | 4 | Robinson James A. Jr. — Director | Disposition to issuer (D): 25,000 (derivative) | EDGAR |
| 2022-12-01 | 4 | Rosen James — Director | Code (U): 1,000 · Disposition to issuer (D): 9,375 (derivative) · Disposition to issuer (D): 4,688 (derivative) · Disposition to issuer (D): 6,200 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +4 more | EDGAR |
| 2022-12-01 | 4 | Aliski William — Director | Code (U): 8,500 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 12,000 (derivative) · Disposition to issuer (D): 14,000 (derivative) | EDGAR |
| 2022-12-01 | 4 | Hashad Yehia — Director | Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 14,000 (derivative) | EDGAR |
| 2022-12-01 | 4 | Koenig Scott — Director | Code (U): 34,246 · Disposition to issuer (D): 14,285 (derivative) · Disposition to issuer (D): 9,375 (derivative) · Disposition to issuer (D): 4,688 (derivative) · Disposition to issuer (D): 6,200 (derivative) · Disposition to issuer (D): 8,000 (derivative) · +5 more | EDGAR |
| 2022-12-01 | 4 | Reynolds Gerald Anthony — Chief Accounting Officer | Code (U): 8,506 · Disposition to issuer (D): 42,500 · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 34,500 (derivative) | EDGAR |
| 2022-12-01 | 4 | Scaria Abraham — Chief Scientific Officer | Disposition to issuer (D): 220,000 (derivative) · Disposition to issuer (D): 124,500 (derivative) | EDGAR |
| 2022-12-01 | 4 | Potter Stephen W — Chief Business Officer | Code (U): 47,133 · Disposition to issuer (D): 8,750 · Disposition to issuer (D): 131,049 (derivative) · Disposition to issuer (D): 51,000 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 50,000 (derivative) · +5 more | EDGAR |
| 2022-12-01 | 4 | DOyley-Gay Hope — General Counsel | Disposition to issuer (D): 180,000 (derivative) · Disposition to issuer (D): 147,900 (derivative) | EDGAR |
| 2022-12-01 | 4 | Schneider Susan — Chief Medical Officer | Disposition to issuer (D): 180,000 (derivative) · Disposition to issuer (D): 142,300 (derivative) | EDGAR |
| 2022-12-01 | 4 | Lieber Jonathan I — Chief Financial Officer | Disposition to issuer (D): 202,000 (derivative) · Disposition to issuer (D): 154,700 (derivative) | EDGAR |
| 2022-12-01 | 4 | Washer Susan B. — President and CEO, Director | Code (U): 143,021 · Disposition to issuer (D): 140,000 (derivative) · Disposition to issuer (D): 99,156 (derivative) · Disposition to issuer (D): 55,780 (derivative) · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · +6 more | EDGAR |
| 2022-12-01 | 4 | VANLENT ANNE — Director | Disposition to issuer (D): 16,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 12,000 (derivative) · +1 more | EDGAR |
| 2022-12-01 | 4 | HURWITZ EDWARD — Director | Code (U): 25,672 · Code (U): 1,800 · Disposition to issuer (D): 9,375 (derivative) · Disposition to issuer (D): 4,688 (derivative) · Disposition to issuer (D): 6,200 (derivative) · Disposition to issuer (D): 8,000 (derivative) · +5 more | EDGAR |
| 2022-08-24 | 4 | Reynolds Gerald Anthony — Chief Accounting Officer | Grant/award (A): 30,000 @ $0 | EDGAR |
| 2022-08-24 | 4 | DOyley-Gay Hope — General Counsel | Grant/award (A): 147,900 (derivative) @ $0 | EDGAR |
| 2022-08-24 | 4 | Potter Stephen W — Chief Business Officer | Grant/award (A): 133,100 (derivative) @ $0 | EDGAR |
| 2022-08-24 | 4 | Scaria Abraham — Chief Scientific Officer | Grant/award (A): 124,500 (derivative) @ $0 | EDGAR |
| 2022-08-24 | 4 | Schneider Susan — Chief Medical Officer | Grant/award (A): 142,300 (derivative) @ $0 | EDGAR |
| 2022-08-24 | 4 | Lieber Jonathan I — Chief Financial Officer | Grant/award (A): 154,700 (derivative) @ $0 | EDGAR |
| 2022-08-24 | 4 | Washer Susan B. — President and CEO, Director | Grant/award (A): 442,000 (derivative) @ $0 | EDGAR |
| 2022-07-01 | 4 | Potter Stephen W — Chief Business Officer | Sale (S): 8,070 @ $0.77 | EDGAR |
| 2022-05-31 | 4 | Reynolds Gerald Anthony — Chief Accounting Officer | Sale (S): 3,994 @ $0.85 | EDGAR |
| 2022-02-22 | 4 | Washer Susan B. — President and CEO, Director | Option exercise (M): 120,686 @ $0.35 · Sale (S): 9,950 @ $2.18 · Option exercise (M): 120,686 (derivative) @ $0 | EDGAR |
| 2021-12-15 | 4 | DOyley-Gay Hope — General Counsel | Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2021-12-07 | 4 | Scaria Abraham — Chief Scientific Officer | Grant/award (A): 220,000 (derivative) @ $0 | EDGAR |
| 2021-12-02 | 4 | Robinson James A. Jr. — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-12-02 | 4 | Rosen James — Director | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2021-12-02 | 4 | Magovcevic-Liebisch Ivana — Director | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2021-12-02 | 4 | Koenig Scott — Director | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2021-12-02 | 4 | Hashad Yehia — Director | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2021-12-02 | 4 | Aliski William — Director | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2021-12-02 | 4 | VANLENT ANNE — Director | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2021-12-02 | 4 | HURWITZ EDWARD — Director | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2021-11-16 | 4 | Schneider Susan — Chief Medical Officer | Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2021-11-03 | 4 | Washer Susan B. — President and CEO, Director | Option exercise (M): 3,877 @ $3.50 · Option exercise (M): 3,877 (derivative) @ $0 | EDGAR |
| 2021-09-21 | 4 | Lieber Jonathan I — Chief Financial Officer | Grant/award (A): 202,000 (derivative) @ $0 | EDGAR |
| 2021-08-18 | 4 | Hashad Yehia — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-08-17 | 4 | Potter Stephen W — Chief Business Officer | Tax withholding (F): 5,724 @ $3.58 | EDGAR |
| 2021-08-06 | 4 | Reynolds Gerald Anthony — Chief Accounting Officer | Grant/award (A): 34,500 (derivative) @ $0 | EDGAR |
| 2021-07-29 | 4 | Potter Stephen W — Chief Business Officer | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2021-07-29 | 4 | Washer Susan B. — President and CEO, Director | Grant/award (A): 275,000 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | Potter Stephen W — Chief Business Officer | Grant/award (A): 35,000 @ $0 | EDGAR |
| 2020-12-18 | 4 | Rosen James — Director | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2020-12-18 | 4 | Magovcevic-Liebisch Ivana — Director | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2020-12-18 | 4 | Aliski William — Director | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2020-12-18 | 4 | Koenig Scott — Director | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2020-12-18 | 4 | VANLENT ANNE — Director | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2020-12-18 | 4 | HURWITZ EDWARD — Director | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2020-08-18 | 4 | Shearman Mark S — Chief Scientific Officer | Tax withholding (F): 5,723 @ $5.77 | EDGAR |
Recent 8-K events — APPLIED GENETIC TECHNOLOGIES CORP
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2022-12-01 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-11-29 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-11-23 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-10-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-08-26 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2022-08-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2022-07-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-06-10 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2022-05-16 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-05-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AGTC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs